Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2001, p. 593-595, Vol. 45, No. 2
Department of Clinical Microbiology and
Infectious Diseases, Hadassah University Hospital, Jerusalem, and
Schneider Children Medical Center, Petach Tiqva, Israel
Received 10 April 2000/Returned for modification 7 August
2000/Accepted 7 November 2000
Infection with multiple ganciclovir-resistant human cytomegalovirus
mutants, containing different substitutions and deletions in the UL97
gene, was found in a patient with severe combined immunodeficiency
(SCID) within 3 weeks of ganciclovir therapy. A novel 11-codon deletion
at positions 590 to 600 was identified. These unique findings may be
related to the nature of the immunodeficiency in the SCID patient.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.2.593-595.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Emergence of Multiple Human Cytomegalovirus Ganciclovir-Resistant
Mutants with Deletions and Substitutions within the UL97 Gene in a
Patient with Severe Combined Immunodeficiency
*
Corresponding author. Mailing address: Dept. of
Clinical Microbiology and Infectious Diseases, Hadassah University
Hospital, P.O.B. 12000, Jerusalem, 91120, Israel. Phone:
972-2-6776-543. Fax: 972-2-6434-434. E-mail:
wolfd{at}md2.huji.ac.il.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»